The seed round was co-led by UK Innovation and Science Seed Fund and Expansion Aerospace Ventures.
"These programmes supported us from day one, helping us combine state-of-the-art research in hyperspectral remote sensing, machine learning and crop growth modelling to build something radically new – turning an ambitious idea into a commercial business with real-world impact. Now we’re ready to take this innovation global, helping farmers boost profits, cut emissions and keep soils healthy for future generations."
The financing round and grant package was co-led by Lockheed Martin Ventures, Chrysalix, and Maven SWIF.
"Our investment in Q5D and its automated electrification technology highlights our dedication to fostering a robust and resilient defense industrial base. Through investments like this one, Lockheed Martin Ventures aims to accelerate the development of next-generation technologies that will enable our customers to stay ahead of emerging threats and maintain a strategic advantage in an increasingly complex security landscape."
The latest investment brings total equity financing to £7.2m and will support clinical progression of internal assets.
"A third of all FDA-approved drugs target GPCRs, yet, despite decades of research and billions of funding, only a few GPCR-targeting antibodies exist. Thanks to the support of our investors, we are one step closer to making GPCRs and other challenging targets druggable, bringing needed therapies to patients across the globe."
TRICAPITAL Angels led the round alongside Scottish Enterprise and UKI2S to support the firm's subsea technology.
"We look forward to working with TRICAPITAL and Scottish Enterprise and to have the continued backing of UKI2S in our journey to change the game for underwater robotics."
The seed round was led by Bloc Ventures with participation from UKI2S and private backers.
"We started manufacturing DielectriX antennas using state of the art laser/robotics equipment developed in-house, and we are now set to scale up rapidly through partnerships with electronics manufacturing service providers in the UK. Future manufacturing growth plans will roll out our 'factory-in-a-box' to deliver global capability required to meet the expected demands for autonomous vehicles and systems where absolute resilience and precision of location data is essential for safety."
The funding round was backed by the Midlands Engine Investment Fund and matched by the UK Future Fund.
"We are very grateful to our existing investors for their continued support and to the UK Future Fund for providing matched funding. The funds received will enable Linear Diagnostics to develop a prototype single use cartridge and reader for our duplex test for chlamydia and gonorrhoea."
.png)
